Structural Biology and Research

Drug Designing

Drug design is also referred as rational drug design. It is an inventive process to find new medication centred on the knowledge of biological target. Drug is most commonly a small molecule that inhibits or activates the function of a biomolecule, which in turn outcomes in a therapeutic benefit to the patient. Drug design commonly but not essentially relies on computational techniques. This type of modelling is often mentioned to as computer-aided drug design. Drug design that depends on the knowledge of the 3D structure of the target is known as structure-based drug design. The main methods available for drug design are structure based drug design and ligand based drug design.

Relevant Conferences

International Conference on Biochemistry, October 10-12, 2016 Kuala Lumpur, Malaysia, USA; 7^th InternationalConference on Proteomics, October 24-26, 2016 Rome, Italy; 3^rd International Conference on Big Data Analysis and Data Mining, September 26-28, 2016 London, UK; 5^th International Conference on Computational Systems Biology, August 22-23, 2016 Philadelphia, USA; International Conference on Nucleic Acids August 04-06, 2016 Seattle, USA; 253^rd ACS National Meeting, April 02-06, 2017 San Francisco, USA; Conference on Membrane Transport Proteins, June 12-17, 2016 Lucca, Italy; Conference on Protein Folding Dynamics, January 10-15, 2016 Galveston, USA; 9^th International Workshop on X-ray Radiation Damage to Biological Crystalline Samples, March 09-11 2016 Lund, Sweden; Biophysical Society’s 60^th Annual Meeting, February 27-March 02 2016 Los Angeles, USA; 15^th European Conference on Computational Biology, September 03-07 2016 The Hague, Netherlands; The 31^st Symposium of The Protein Society, July 24-27, 2017 Montreal, Canada.